Latest Pharmaceuticals News

Page 14 of 89
AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.
Ada Torres
Ada Torres
29 July 2026
Emyria has expanded its Empax clinic network across four states, reporting a 210% revenue increase in FY26 and early clinical success in treatment-resistant depression.
Ada Torres
Ada Torres
29 July 2026
Clean TeQ Water has commissioned its first full-scale PHOSPHIX® phosphate removal plant in Europe, surpassing regulatory and contractual standards and setting a commercial benchmark for future growth.
Victor Sage
Victor Sage
28 July 2026
LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.
Victor Sage
Victor Sage
28 July 2026
Elixinol Wellness posted a record quarterly revenue of $4.3 million in Q2 FY26, driven by The Healthy Chef's expansion and a 45% gross margin. Cost cuts helped deliver positive underlying operating cash flow for the third straight quarter despite some one-off expenses.
Victor Sage
Victor Sage
28 July 2026
Clinuvel Pharmaceuticals targets year-end for topline results from its pivotal vitiligo trial of SCENESSE® combined with narrowband UVB, aiming to expand the drug's use beyond its current rare disease indication.
Ada Torres
Ada Torres
28 July 2026
Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.
Ada Torres
Ada Torres
28 July 2026
Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.
Ada Torres
Ada Torres
27 July 2026
Australian Foundation Investment Company (ASX:AFI) posted a 3% increase in net profit for FY26, holding dividends steady with a special payout amid portfolio underperformance against the ASX 200.
Victor Sage
Victor Sage
27 July 2026
BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.
Ada Torres
Ada Torres
27 July 2026
Xenitra has secured a three-year procurement agreement worth at least A$12 million with Kangsheng, a leading Chinese pharmaceutical distributor, marking its OTC pharmaceuticals division's shift from setup to commercial execution.
Ada Torres
Ada Torres
27 July 2026
BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.
Victor Sage
Victor Sage
27 July 2026

Browse the archive

Full archive